Parameswaran Venugopal MD

Hematologic Oncology

Consultants in Hematology

1725 West Harrison Street, Suite 809.Chicago, IL 60612
Phone+1 312-942-5978
Fax+1 312-942-3192

Dr. Venugopal is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Venugopal's full profile Already have an account?

Summary

Dr. Parameswaran Venugopal is a hematologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center and Rush Oak Park Hospital. He received his medical degree from University of Kerala Medical College and has been in practice 41 years. He specializes in hematologic oncology and is experienced in hematologic oncology.

Education & Training

Rush University Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1996
Rush University Medical CenterResidency, Internal Medicine, 1993 - 1994
Henry Ford Health/Henry Ford HospitalInternship, Internal Medicine, 1992 - 1993
University of LondonDiploma, Clinical Pathology, 1989
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1976 - 1979

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IL State Medical License 1994 - 2029
MI State Medical License 1992 - 1993
National Board of Physicians and Surgeons Hematology
National Board of Physicians and Surgeons Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017

Clinical Trials

Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
COMPLETED
PHASE2
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
COMPLETED
PHASE3

Publications & Presentations

PubMed

1 citations
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL.
Kirk Cahill, James Godfrey, Chadi Nabhan, Justin Kline, Peter A Riedell
Blood Advances. 2025-11-11
Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy.
Oluwatobi Odetola, Shuo Ma, Jane Winter, Barbara Pro, Ishan Roy
Blood Advances. 2025-11-11
3 citations
Acalabrutinib alone or in combination with rituximab for follicular lymphoma: An open-label study.
Paolo Strati, Rebecca Champion, Morton Coleman, Sonali M Smith, Parameswaran Venugopal
British Journal of Haematology. 2024-12-01

Journal Articles

The Present and Future Cardiovascular Medicine and Society the Cardiologist and the Cancer Patient: Challenges to Cardio-Oncology (Or Onco-Cardiology) and Call to Action
Agne Paner, Hena Patel, Timothy Kuzel, Parameswaran Venugopal, Tochi M Okwuosa, Nicole Prabhu, Kim A Williams, ScienceDirect
Impact of Insulin-Like Growth Factor-1 & Insulin-Like Growth Factor Binding Protiens On Outcomes in Acute Myeloid Leukemia
Karmali, Reem; Larson, Melissa L; Shammo, Jamile; Basu, Sanjib; Christopherson, Kent W; Borgia, Jeffery A; Venugopal, Parameswaran, Leukemia & Lymphoma, 1/1/2015
A phase III open label randomized study of cytarabine in comibination with amonafide L-malate or daunorubicin as inducation therapy for patients with secondary acute ...
Richard Stone, Emmanuele Mazola, Steven L Allen, Arnaud Pigneux, Robert K. Stuart, Meir Wetzler, David Rizzieri, Harry Paul Erba, Lloyd Damon, Junho Jang, Martin S. Ta..., Journal of Clinical Oncology, 1/1/2015

Books/Book Chapters

Management of Hematologic Malignancies
Chapter: Treatment Approaches to MALT/Marginal Zone Lymphomas
Stephanie A. Gregory and Parameswaran VenugopalEditors: Susan O'Brien, Julie M. Vose and Hagop M. Kantarjian.Cambridge Books2011
ASHTM-SAP. American Society of Hematology Self Assessment Program
Chapter: Lymphoproliferative Disorders
Page 265 - 297Venugopal, P and Gregory, S.AEditors: S.A. Gregory and M.J. Kahn.American Society of Hematology, Washington, DCEdition 3rd,2007
Cancer, Principles and practice of oncology review
Page 376 - 390William T. Leslie and Parameswaran Venugopal. Hodkin Disease and Non-Hodgkin Lymphomas in Devita, Hellman, and Rosenberg’sEditors: Ramaswamy Govindan.Lippincott Williams and WilkinsEdition 1st,2005

Abstracts/Posters

The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
Parameswaran Venugopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
Parameswaran Venugopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Marked lymphocytosis in Hairy Cell Leukemia: Need for caution when diagnosing Variant Hairy Cell Leukemia
Sahr Syed, Jason Macklis, Parameswaran Venugopal, Brett Mahon, CAP’15 meeting, Nashville, TN, 1/7/2015

Lectures

Copanlisib for Follicular Lymphoma. FDA Approvals and Their Incorporation into Clinical Practice
2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
Management of High Risk Aggressive Lymphoma
Coeur d'alene, ID - 1/28/2015
Hodgkin Lymphoma, management
1/26/2015

Press Mentions

‘I Love What I Do’April 11th, 2025
Nurse Rescues Stranger in Fiery WreckMay 11th, 2022
Lessons Learned About Dying from a Dying Son, on World Cancer Day 2020January 30th, 2020